BioSpace News Archive

Researchers from around the world are coming to present scientific research and clinical trial data for the disease.

The 12th Clinical Trials on Alzheimer’s Disease conference kicks off today. One of the big stories, which will be presented on Thursday, December 5, is detailed results from Biogen’s Phase III clinical trials of aducanumab.

These are the top biotech companies headquartered in Biotech Beach based on 2018 revenue. Here’s the brief information including the revenue of each company.

Capitalizing on artificial intelligence to accelerate the development of therapeutic antibodies — drugs of the future.

Da Volterra, a clinical-stage biopharmaceutical company developing innovative products to protect the intestinal microbiota, announced the results of DAV132CL-1005, a Phase 1 clinical study which investigated the potential effect of DAV132 on the bioavailability of warfarin or clonazepam, two widely used drugs with narrow therapeutic index.

Pharmapack 2020 gathering top specialists and pioneers to exchange their vision on best strategies to tackle key challenges

Researchers have found a new way to use math to better treat cancer and prevent its relapse.

Several trends have emerged in synthetic biology since the field developed nearly 20 years ago. In that time, some technologies have crystallized and developed into key trends that crop up time again within synthetic biology conversations.

Companies from across the globe provide updates on their business and pipelines.

The technology at the heart of Nanopareil revolves around nanofibers a thousand times smaller than a human hair, but its potential impact on the pharmaceutical industry could be massive.